“ Aspen Malaysia’s country manager details the company’s success in the country with a specific business model based on acquiring and remarketing originators. Although Aspen is a renowned… ”
In Conversation
“ MGCC’s Executive Director discusses the opportunities and challenges for German pharma and healthcare companies to invest in Malaysia, at a time where most have decided to… ”
“ Clinical Research Malaysia’s CEO discusses the need for Malaysia to focus on high quality pivotal trials rather than simply on a high number of trials. He… ”
IJN National Heart Institute – Tan Sri Dato’ Seri Dr. Robaayah Zambahari, Chief Executive Director – Malaysia
“ The National Heart Institute’s CEO portrays IJN as a national referral center for cardiovascular disease and declares: “IJN is equipped with the best in class technologies… ”
“ “We believe the future lies with Universal health coverage and the formulation of one and only healthcare, with the merger of public and private sector under… ”
“ PEMANDU’s Director for the Healthcare National Key Economic Area gives a thorough understanding of the various entry point projects that were implemented since 2010 to help… ”
Stefan Oschmann, President of the Emerging Markets at Merck and Co. described MSD as the dark horse of the emerging markets. How is MSD performing in…
PhAMA was started in 1972 and now has most of the MNC players among its members which include 43 companies. How has the association evolved since…
Interview with Leonard Ariff Abdul Shatar, President, Malaysian Organisation of Pharmaceutical Industries (MOPI)
The pharmaceutical industry has been targeted as one of the key growth sectors for the Malaysian economy under the 10th Malaysia Plan, how successful in your…
2011 marks the 10th anniversary of the company. Over that time you’ve enjoyed notable success including being the first Asian CRO to attain OECD GLP accreditation.…
Since its origin, Emerging Pharma has been helping foreign pharma companies to enter Malaysia. However, the Malaysian market is relatively small. Why should international pharma companies…
Interview with Dato’ Noharuddin Nordin , CEO, Malaysia External Trade Development Corporation (MATRADE)
How would you describe the operating environment for foreign companies to use the services of Malaysian companies and how can you reassure these multinationals that sufficient…